e.g. mhealth
Search Results (1 to 10 of 16 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 5 JMIR Research Protocols
- 4 JMIRx Med
- 3 JMIR Public Health and Surveillance
- 2 Journal of Medical Internet Research
- 1 JMIR Formative Research
- 1 JMIR Human Factors
- 0 Medicine 2.0
- 0 Interactive Journal of Medical Research
- 0 iProceedings
- 0 JMIR Medical Informatics
- 0 JMIR mHealth and uHealth
- 0 JMIR Serious Games
- 0 JMIR Mental Health
- 0 JMIR Rehabilitation and Assistive Technologies
- 0 JMIR Preprints
- 0 JMIR Bioinformatics and Biotechnology
- 0 JMIR Medical Education
- 0 JMIR Cancer
- 0 JMIR Challenges
- 0 JMIR Diabetes
- 0 JMIR Biomedical Engineering
- 0 JMIR Data
- 0 JMIR Cardio
- 0 Journal of Participatory Medicine
- 0 JMIR Dermatology
- 0 JMIR Pediatrics and Parenting
- 0 JMIR Aging
- 0 JMIR Perioperative Medicine
- 0 JMIR Nursing
- 0 JMIRx Bio
- 0 JMIR Infodemiology
- 0 Transfer Hub (manuscript eXchange)
- 0 JMIR AI
- 0 JMIR Neurotechnology
- 0 Asian/Pacific Island Nursing Journal
- 0 Online Journal of Public Health Informatics
- 0 JMIR XR and Spatial Computing (JMXR)
This is the peer-review report for “Identification of COVID-19–Associated Hepatitis in Children as an Emerging Complication in the Wake of SARS-Co V-2 Infections: Ambispective Observational Study.”
This paper [1] looks appropriate and relevant. Some corrections are needed. Additionally, none of the figures (except x-rays and study workflow) are properly visible on the PDF or Word version, so I cannot comment on their content. Please provide better-quality pictures, if possible.
JMIRx Med 2024;5:e60168
Download Citation: END BibTex RIS
This is the peer-review report for “Identification of COVID-19–Associated Hepatitis in Children as an Emerging Complication in the Wake of SARS-Co V-2 Infections: Ambispective Observational Study.”
COVID-19–associated hepatitis in children (CAH-C) during the second wave of SARS-Co V-2 infections in Central India: is it a complication or transient phenomenon?
The topics of this paper [1] are interesting but the results are not clear and robust.
JMIRx Med 2024;5:e59596
Download Citation: END BibTex RIS
In this scenario our study identified 37 cases with a unique presentation of acute hepatitis designated as CAH-C, whereas MIS-C could account for hepatitis in 10 cases amongst 15873 children screened in the district during the study period.” The number 15,873 in the Results section was previously mentioned as all screened patients regardless of age, and only 475 (2.99%) were actually children. Please correct or elaborate.
Response: Thank you for pointing out this discrepancy.
JMIRx Med 2024;5:e59327
Download Citation: END BibTex RIS

During the ongoing phase of the pandemic, apart from children with MIS-C, there was another group of children presenting with hepatitis. This unique presentation of hepatitis was temporally associated with SARS-Co V-2 infections, which is designated by us as COVID-19–associated hepatitis in children (CAH-C). Such hepatitis cases outnumbered MIS-C cases and lacked the hallmarks of inflammation seen in MIS-C.
JMIRx Med 2024;5:e48629
Download Citation: END BibTex RIS

Additionally, people with OUD have high hepatitis C virus (HCV) incidence and prevalence due to injection drug use and limited access to HCV therapy [3]. To achieve HCV elimination by 2030, as proposed in several jurisdictions [4-6], HCV treatment access must increase.
We sought to address restricted HCV care access for people with OUD through a randomized controlled trial of care integration using technology that is at the intersection of the internet or videoconferencing, and health care.
J Med Internet Res 2024;26:e53049
Download Citation: END BibTex RIS

Initially, awareness of HCV was determined based on participant responses to the following question: “Have you ever heard of hepatitis C disease or hepatitis C virus (HCV)?” Individuals who replied yes were considered as being aware of HCV and asked additional questions to assess the depth of their HCV knowledge based on surveys conducted previously [18,19].
JMIR Public Health Surveill 2023;9:e39472
Download Citation: END BibTex RIS

Migrants are disproportionately affected by HIV, hepatitis B virus (HBV), and hepatitis C virus (HCV). A meta-analysis comparing migrants with native-born populations found that migrants have a high HIV prevalence ratio [1]. A recent French study found that among migrants living with HIV, HBV, or HCV, 56%, 71%, and 89% were respectively diagnosed in France [2], whereas another study reported that 57% of migrants who are HIV positive acquired the virus while in the country [3].
JMIR Form Res 2023;7:e49251
Download Citation: END BibTex RIS

Hepatitis A (Hep A) is a viral infection of the liver caused by the hepatitis A virus (HAV). HAV is transmitted through the fecal-oral route, mainly by exposure to contaminated water sources. Hep A outbreaks are uncommon in the United Kingdom, and most people manifest mild to moderate symptoms that tend to resolve, without sequelae, within several months.
JMIR Res Protoc 2023;12:e51861
Download Citation: END BibTex RIS

In 2020, the USPSTF and CDC recommended that all pregnant persons be screened during each pregnancy for hepatitis C [14]. However, there are limited data on trends in hepatitis C testing during pregnancy. We estimated hepatitis C testing rates in a large cohort of patients with Medicaid and commercial insurance who gave birth during 2015-2019 and described demographic and risk-based factors associated with testing.
JMIR Public Health Surveill 2023;9:e40783
Download Citation: END BibTex RIS

Cirrhosis can be caused by chronic viral hepatitis (B and C), chronic alcohol abuse, inherited metabolic diseases such as genetic haemochromatosis, or in some cases alpha-1-antitrypsin deficiency. The acquired metabolic disorder, nonalcoholic fatty liver disease (NAFLD), has also emerged as an important risk factor. NAFLD is a manifestation of the metabolic syndrome and is associated with type 2 diabetes mellitus and obesity. NAFLD affects around 20% to 30% of the adult population.
JMIR Res Protoc 2023;12:e44264
Download Citation: END BibTex RIS